Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoling Shang

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|November 4, 2022
Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysisHandai Xia, Wengang Zhang, Yuqing Zhang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|September 27, 2021
Trefoil Factor 3 Inhibits Thyroid Cancer Cell Progression Related to IL-6/JAK/STAT3 Signaling PathwayYunchao Xin, Xiaoling Shang, Xiaoran Sun, et al.
Heliyon|July 22, 2024
Decorin impeded the advancement of thyroid papillary carcinoma by thwarting the EGFR/ FER/ SHP2 signaling-induced sustenance of early endosomesYaping Liu, Yunchao Xin, Tianyun Lv, et al.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|July 13, 2022
[Risk factors of skip lateral cervical lymph node metastasis in papillary thyroid carcinoma]Jie Gao, Yunchao Xin, Lihang Yang, et al.
Cancer Medicine|July 31, 2021
A clinical variable-based nomogram could predict the survival for advanced NSCLC patients receiving second-line atezolizumabXiaoling Shang, Jianxiang Shi, Xiaohui Wang, et al.
Bioengineered|May 23, 2022
SLC8A1 antisense RNA 1 suppresses papillary thyroid cancer malignant progression via the FUS RNA binding protein (FUS)/NUMB like endocytic adaptor protein (Numbl) axisYunchao Xin, Xiaoling Shang, Xiaoran Sun, et al.
Future Oncology (London, England)|August 9, 2019
Poor survival of non-small-cell lung cancer patients with main bronchus tumor: a large population-based studyCheng Li, Jia Liu, Jiamao Lin, et al.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|April 18, 2014
[The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma]Gang Xue, Jing Huang, Huiqin Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|February 28, 2021
Survival analysis for non-squamous NSCLC patients harbored STK11 or KEAP1 mutation receiving atezolizumabXiaoling Shang, Zhenxiang Li, Jian Sun, et al.
Applied Bionics and Biomechanics|August 29, 2022
An Intelligent Health Monitoring Model Based on Fuzzy Deep Neural NetworkTianye Xing, Yidan Wang, Yingxue Liu, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|November 4, 2022
Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysisHandai Xia, Wengang Zhang, Yuqing Zhang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|September 27, 2021
Trefoil Factor 3 Inhibits Thyroid Cancer Cell Progression Related to IL-6/JAK/STAT3 Signaling PathwayYunchao Xin, Xiaoling Shang, Xiaoran Sun, et al.
Heliyon|July 22, 2024
Decorin impeded the advancement of thyroid papillary carcinoma by thwarting the EGFR/ FER/ SHP2 signaling-induced sustenance of early endosomesYaping Liu, Yunchao Xin, Tianyun Lv, et al.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|July 13, 2022
[Risk factors of skip lateral cervical lymph node metastasis in papillary thyroid carcinoma]Jie Gao, Yunchao Xin, Lihang Yang, et al.
Cancer Medicine|July 31, 2021
A clinical variable-based nomogram could predict the survival for advanced NSCLC patients receiving second-line atezolizumabXiaoling Shang, Jianxiang Shi, Xiaohui Wang, et al.
Bioengineered|May 23, 2022
SLC8A1 antisense RNA 1 suppresses papillary thyroid cancer malignant progression via the FUS RNA binding protein (FUS)/NUMB like endocytic adaptor protein (Numbl) axisYunchao Xin, Xiaoling Shang, Xiaoran Sun, et al.
Future Oncology (London, England)|August 9, 2019
Poor survival of non-small-cell lung cancer patients with main bronchus tumor: a large population-based studyCheng Li, Jia Liu, Jiamao Lin, et al.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|April 18, 2014
[The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma]Gang Xue, Jing Huang, Huiqin Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|February 28, 2021
Survival analysis for non-squamous NSCLC patients harbored STK11 or KEAP1 mutation receiving atezolizumabXiaoling Shang, Zhenxiang Li, Jian Sun, et al.
Applied Bionics and Biomechanics|August 29, 2022
An Intelligent Health Monitoring Model Based on Fuzzy Deep Neural NetworkTianye Xing, Yidan Wang, Yingxue Liu, et al.
Pageof 7